Concepedia

Author

Doerthe Eckert

AbbVie (United States)ORCID

Also Known As

Chih-Wei Lin, D. Eckert, Doerthe Eckert, Dunja kalamera

32

Publications

393

Citations

10

H-Index

16

Concepts

All Affiliations

AbbVie (United States)AbbVie (Germany)Ludwigshafen University of Business and SocietyKlinikum Ludwigshafen
DE

About

Doerthe Eckert is an author at AbbVie (United States) specializing in medicine, hematology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

146

2

Immunology

2

2

73

3

Pharmacology

2

2

73

4

Health Sciences

1

1

44

5

Gastroenterology

1

1

12

Doerthe Eckert

×

8

Publications

287

Citations

8

H-Index

YearCitations

Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohnʼs Disease

Shringi Sharma, Doerthe Eckert, Jeffrey S. Hyams,

Inflammatory Bowel Diseases

2015

97

Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia

Kevin J. Freise, Aksana K. Jones, Doerthe Eckert,

Clinical Pharmacokinetics

2016

61

Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy

Deanna J. Brackman, Doerthe Eckert, Rajeev Menon,

Hematological Oncology

2022

44

Pharmacokinetics of Risankizumab in Asian Healthy Subjects and Patients With Moderate to Severe Plaque Psoriasis, Generalized Pustular Psoriasis, and Erythrodermic Psoriasis

Amit Khatri, Doerthe Eckert, Rajneet K. Oberoi,

The Journal of Clinical Pharmacology

2019

29

Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients

Ana Victoria Ponce Bobadilla, Sven Stodtmann, Doerthe Eckert,

Clinical Pharmacokinetics

2022

16

Population pharmacokinetics of paritaprevir, ombitasvir, dasabuvir, ritonavir and ribavirin in hepatitis C virus genotype 1 infection: analysis of six phase III trials

Sven Mensing, Doerthe Eckert, Shringi Sharma,

British Journal of Clinical Pharmacology

2016

15

Population pharmacokinetic and exposure‐response modelling to inform upadacitinib dose selection in adolescent and adult patients with atopic dermatitis

Mohamed A. Ismail, Eva Doelger, Doerthe Eckert,

British Journal of Clinical Pharmacology

2023

13

Sa1195 Exposure-Efficacy Relationship (ER) for Adalimumab During Induction Phase of Treatment of Adult Patients With Moderate to Severe Ulcerative Colitis

Nael M. Mostafa, Doerthe Eckert, Rajendra Pradhan,

Gastroenterology

2013

12

Page 1